Operating Expenses -- Decreased by $1.7 million in the third fiscal quarter ending June 2025, and excluding a $2 million ...

Freedom Bank Kazakhstan, a part of Freedom Holding Corp., a NASDAQ-listed finance and technology group, received the award in ...

Floquet control uses time-periodic drives to engineer quantum systems, creating dynamic changes in material properties ...

Privosegtor is advancing in the registrational PIONEER program across 2 key optic neuropathies, representing an unaddressed potential market of $7 billion in the U.S. Privosegtor achieved an average ...

Summary By Aria Deemie, climate change reporter with New Narratives WUNGKO FARM, Salala – The afternoon sun comes out after a ...

The Maine Municipal Bond Bank is bringing back its transportation revenue bond program, with a few changes to bolster the ...

President Donald Trump and former Secretary of Transportation Pete Buttigieg have sparred over the condition of the air ...

Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...

UCLA scientists have characterized the structure and function of a key survival protein in breast cancer cells that helps explain how these tumors resist environmental stress and thrive in acidic, low ...